Skip to content

MARAGANORE JOHN

Reporting owner on Forms 3, 4 and 5, CIK 1180432.

MARAGANORE JOHN reported on 2 issuers in 3 filings, the latest a Form 4 filed 2026-10-22.

Issuers

IssuerRoles in the latest filingFilingsLast filed
RAPP · Rapport Therapeutics, Inc.CIK 2012593director12026-10-22
CITY THERAPEUTICS, INC. CIK 2143850director22026-10-19

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
RAPP · Rapport Therapeutics, Inc.Common Stock2026-10-22P bought+8,239$26.37998,239Form 4
RAPP · Rapport Therapeutics, Inc.Common Stock2026-10-22P bought+1,172$26.91739,411Form 4
CITY THERAPEUTICS, INC. Common Stock2026-10-19C converted+610,7591,470,692Form 4
CITY THERAPEUTICS, INC. Series Seed convertible preferred stock, derivative2026-10-19C converted-500,000$00Form 4
CITY THERAPEUTICS, INC. Series A convertible preferred stock, derivative2026-10-19C converted-56,095$00Form 4
CITY THERAPEUTICS, INC. Common Stock, holding 318,507Form 4
CITY THERAPEUTICS, INC. Common Stock, holding 318,507Form 4
CITY THERAPEUTICS, INC. Stock Option (Right to Buy), derivative2026-10-15A granted+22,649$022,649Form 4
CITY THERAPEUTICS, INC. Common Stock, holding 859,933Form 3
CITY THERAPEUTICS, INC. Common Stock, holding 318,507Form 3
CITY THERAPEUTICS, INC. Common Stock, holding 318,507Form 3
CITY THERAPEUTICS, INC. Series Seed convertible preferred stock, derivative, holding Form 3
CITY THERAPEUTICS, INC. Series A convertible preferred stock, derivative, holding Form 3
CITY THERAPEUTICS, INC. Stock Option (Right to Buy), derivative, holding Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001193125-26-429071 Rapport Therapeutics, Inc.2026-10-22
Form 4 0001104659-26-116963 CITY THERAPEUTICS, INC.2026-10-19
Form 3 0001104659-26-116349 CITY THERAPEUTICS, INC.2026-10-15